Drug intelligence / Profile preview

Irix

Development stage
Unknown
Lead developer
Pannonpharma
Administration
Topical
01

Overview

Irix is a topical medicinal spray developed and marketed by PannonPharma for the treatment of minor skin injuries, including first-degree burns, sunburns, and insect bites. The active component is an extract derived from rosehip (*Rosa canina*), which is rich in bioactive compounds such as flavonoids, vitamin C, and carotenoids. These constituents contribute to the product's anti-inflammatory properties and its ability to promote epithelialization and skin regeneration. Irix is formulated in an alcoholic solution that provides an immediate cooling sensation upon application, helping to alleviate pain and redness associated with localized skin irritation. It is widely used in the Hungarian market as an over-the-counter remedy for minor thermal and solar skin damage.

Brand names
Irix
Other names
Irix spray

Beyond the preview

Go deeper on Irix.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Irix.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call